Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-11-001760
Filing Date
2011-08-10
Accepted
2011-08-10 16:07:31
Documents
9
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 SIGNPATH PHARMA INC. FORM 10-Q JUNE 30, 2011 signpath10q20110630.htm 10-Q 591303
2 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUAN ex311.htm EX-31.1 17131
3 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUAN ex321.htm EX-32.1 9480
  Complete submission text file 0001096906-11-001760.txt   1866125

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE sppxbrl-20110630.xml EX-101.INS 245481
5 XBRL SCHEMA sppxbrl-20110630.xsd EX-101.SCH 9249
6 XBRL CALCULATION sppxbrl-20110630_cal.xml EX-101.CAL 5425
7 XBRL DEFINITION sppxbrl-20110630_def.xml EX-101.DEF 40533
8 XBRL LABEL sppxbrl-20110630_lab.xml EX-101.LAB 73839
9 XBRL PRESENTATION sppxbrl-20110630_pre.xml EX-101.PRE 54775
Mailing Address 1375 CALIFORNIA ROAD QUAKERTOWN PA 18951
Business Address 1375 CALIFORNIA ROAD QUAKERTOWN PA 18951 267-772-0107
SignPath Pharma, Inc. (Filer) CIK: 0001455694 (see all company filings)

EIN.: 205079533 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-158474 | Film No.: 111024492
SIC: 2834 Pharmaceutical Preparations